SPARTANBURG COMMUNITY CLINICAL ONCOLOGY PROGRAM

斯帕坦堡社区临床肿瘤学计划(SCCOP)已经成为 从CCOP计划一开始就是该计划的热情参与者。自.以来 1983年SCCOP在所有新诊断的癌症中积累了10%以上 在我们的区域肿瘤登记中的患者使用以下癌症治疗方案 高质量、低单位应计成本的数据在这个农村CCOP。这个 每年的平均应计利润为102美元，这与每年的平均水平相比是有利的 如RFA中所述，治疗应计CCOP范围为86。 SCCOP在2006财年收集了100名癌症控制方案的受试者， 相当于每年109.6个受试者的平均应计CCOP范围为 在RFA中陈述的。 SCCOP认为，参与NCI批准了癌症治疗和 癌症控制方案活动是带来最新进展的理想方式 向我们的成员介绍癌症治疗和癌症控制的研究 让我们的社区更广泛地参与这类活动。 这一参与将转移癌症方面的新开发技术 预防、早期发现、治疗、病人管理、康复 并以更快的速度继续关爱我们的社区 相应地降低癌症发病率、发病率和死亡率。 SCCOP在此授权期的目标是维持和扩大我们的 癌症治疗的收益和发展全面的癌症控制 试验计划。这将通过招募更多的 专科调查员(耳鼻喉科、泌尿科、外科肿瘤科、妇科) 癌症治疗和癌症控制活动，包括 斯帕坦堡地区医疗中心的家庭实践住院医师计划 以及参与癌症控制活动的私人执业初级保健医生。 SCCOP将继续作为SWOG、CCWFU、NSABP和MDACC的附属机构 研究基地。这笔赠款将为以下三项全职同等职位提供资助 数据管理。财团医院，作为衡量其 对CCOP计划的承诺，正在为其中一个提供大量资金 FTE(秘书/数据经理)和用于旅行和癌症的额外资金 控制数据管理活动。 SCCOP在这个时候积极地重新竞争继续提供资金 因为这项活动为这个社区带来了巨大的回报。

The Spartanburg Community Clinical Oncology Program (SCCOP) has been an enthusiastic participant in the CCOP program since its inception. Since 1983 SCCOP has accrued greater than 10% of all newly diagnosed cancer patients in our regional tumor registry to cancer treatment protocols with data of high quality and low cost per accrual in this rural CCOP. The average accrual per year of 102 compares favorably with the average yearly treatment accrual CCOP wide of 86 as stated in the RFA. The SCCOP accrued 100 subjects to cancer control protocols in FY-06, equivalent to the average accrual CCOP wide of 109.6 subjects per year as stated in the RFA. SCCOP believes that participation in NCI approved cancer treatment and cancer control protocol activities is an ideal way to bring state-of-the- art cancer treatment and cancer control research to members of our community and involve a wider segment of our community in such activities. This participation will transfer newly developed technology in cancer prevention, early detection, treatment, patient management, rehabilitation and continuing care to our community in an accelerated fashion and correspondingly reduce cancer incidence, morbidity and mortality. The goals of the SCCOP for this grant period are to maintain and expand our cancer treatment accruals and to develop a comprehensive cancer control trials program. This will be accomplished by enlisting a larger number of subspecialty investigators (ENT, urology, surgical oncology, gynecology) in cancer treatment and cancer control activities, and encompassing both the family practice residency program at Spartanburg Regional Medical Center and private practice primary care physicians in cancer control activities. The SCCOP will continue to affiliate with SWOG, CCWFU, NSABP, and MDACC as research bases. The grant will support three full-time equivalents for data management. The consortium hospitals, as a measure of their commitment to the CCOP program, are providing significant funding for one FTE (secretary/data manager) and additional funds for travel and cancer control data management activities. The SCCOP enthusiastically recompetes at this time for continued funding for an activity which has proven extremely rewarding for this community.